Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
108 Results for "
CEACAM
" in MedChemExpress (MCE) Product Catalog:
Products (108)
108 Results for "CEACAM" in MCE Product Catalog:
2
Target:
Forschungsgebiete:
2
1
1 Cited Publications
Art. -Nr.: HY-P99542
CAS. Nr.: 2254086-60-5
Synonyms: SAR-408701; HuMAb2-3-SPDB-DM4
Forschungsgebiete:
Art. -Nr.: HY-P99054
CAS. Nr.: 2349294-95-5
Synonyms: SAR-408377; PF-08046050 Antibody; SAR445953 Antibody
Forschungsgebiete:
Art. -Nr.: HY-177434
CAS. Nr.: 2873366-83-5
Synonyms: Precem-TcT; M 9140
Art. -Nr.: HY-163028
CAS. Nr.: 459789-75-4
ML-T7 is a potent Tim-3 inhibitor. ML-T7 blocks Tim-3 interactions with PtdSer and CEACAM1. ML-T7 not only enhances the antitumor activity of adoptive transfer therapy with cytotoxic T lymphocytes (CTLs) and CAR T cells but also increases the effector function of T cell. ML-T7 promotes NK cells’ killing activity against tumor cells and DC antigen-presenting capacity. ML-T7 directly exerts antitumor efficacy in preclinical tumor models either alone or in combination with Nivolumab (HY-P9903A). ML-T7 can be used for tumor immunotherapy research .
Art. -Nr.: HY-P99681
CAS. Nr.: 1469876-18-3
Synonyms: IMMU 130; hMN-14-SN-38
Target:
Forschungsgebiete:
Labetuzumab govitecan (IMMU 130) is an Anti-CEACAM5/SN-38 antibody-drug conjugate (ADC). Labetuzumab govitecan consists of the antibody Labetuzumab, SN-38, and a pH-sensitive Linker. Labetuzumab govitecan can be used for research of cancers, such as colorectal cancer .
Art. -Nr.: HY-P990940
CAS. Nr.: 2883118-92-9
Synonyms: MBE-748; M-9140 Antibody; MBE-2882 Antibody
Target:
Forschungsgebiete:
TIM-3-IN-2 is a TIM-3 inhibitor. TIM-3-IN-2 blocks the interactions of TIM-3 with PtdSer, CEACAM1 and Gal-9, and inhibits the immunosuppressive function of TIM-3. TIM-3-IN-2 restores IFNγ release from peripheral blood mononuclear cells. TIM-3-IN-2 inhibits the proliferation of acute myeloid leukemia cells. TIM-3-IN-2 can be used for the research of acute myeloid leukemia .
Art. -Nr.: HY-P991060
CAS. Nr.: 1622305-37-6
Target:
Forschungsgebiete:
Art. -Nr.: HY-P990821
Target:
Forschungsgebiete:
Art. -Nr.: HY-P990634
Target:
Forschungsgebiete:
Art. -Nr.: HY-P990569
CAS. Nr.: 1783801-93-3
Synonyms: MK-6018
Target:
Forschungsgebiete:
Art. -Nr.: HY-159884
CAS. Nr.: 328540-44-9
Target:
Forschungsgebiete:
MG-T-19 is a potent small-molecule inhibitor targeting human TIM-3. MG-T-19 blocks the interactions between TIM-3 and its ligands such as phosphatidylserine, CEACAM1 and Galectin-9. MG-T-19 promotes the secretion of TNF-α and IFN-γ by peripheral blood mononuclear cells, and significantly enhances their ability to inhibit cancer cell proliferation. MG-T-19 can be used in studies related to acute myeloid leukemia .
Art. -Nr.: HY-P991198
Art. -Nr.: HY-RS02435
Target:
Forschungsgebiete:
CEACAM1 Human Pre-designed siRNA Set A contains three designed siRNAs for CEACAM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Art. -Nr.: HY-RS17387
Target:
Forschungsgebiete:
Ceacam1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ceacam1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Art. -Nr.: HY-P991469
Synonyms: MEDI-565
Target:
Forschungsgebiete:
Art. -Nr.: HY-P991563
Target:
Forschungsgebiete:
Art. -Nr.: HY-P990852
Target:
Forschungsgebiete:
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
